AI in Eye Care: What It Means for Independent Practice

Artificial intelligence, augmented reality and smart contact lens technology are reshaping the practice of optometry in 2026. These are not future projections. They are the trends clinical bodies, industry analysts and practising optometrists are identifying right now — and independent practice owners need to understand what they mean before the technology arrives at the front door.

Both the American Optometric Association and clinical technology company IbisVision have identified AI as the single biggest force shaping optometry this year. IbisVision puts it plainly: AI-powered diagnostics will become a standard part of the patient experience in 2026, making care faster, smarter and more accurate. The AOA frames it similarly — advances in AI, machine learning, virtual reality and augmented reality are expected to change how optometrists diagnose, manage and treat eye-related problems at a fundamental level.

What that means in practice is worth unpacking carefully.

AI is personalising the clinical encounter.

The trend identified across the sector is not simply faster diagnostics. It is more individualised care. Large datasets and AI-powered analytics tools are enabling a shift toward genuinely personalised recommendations — for eyeglasses, for contact lenses, for clinical management pathways. The technology is enabling recommendations to be tailored to the specific patient in the chair rather than to a population average.

For independent practice, that distinction matters. A clinical encounter built around a detailed, data-informed personal recommendation is the opposite of the high-volume, standardised model that corporate multiples rely on. AI does not have to mean faster throughput. In the right practice, it means a more substantive clinical conversation, better supported by data.

The AOA has also flagged telehealth, online vision screening and chairside innovations as forces shaping the sector — alongside the growing influence of social media on patient awareness and the public’s desire for convenience. These are not threats to manage. They are the context in which independent practice now operates and competes.

Myopia is being reclassified. The implications are significant.

At the American Academy of Optometry’s 2025 annual meeting in Boston, Langis Michaud from the Université de Montréal School of Optometry made a point that should be on every independent practice owner’s agenda. Myopia control is a collective effort — involving every staff member, starting with the front-of-house. And myopia must be treated as a genuine disease, not merely a refractive error.

That framing changes the clinical conversation. Successful myopia control, particularly in children, can prevent complications of the disease that cause blindness. The availability of myopia-controlling spectacle lenses now gives practices another effective clinical tool alongside contact lens options — and the range of treatment choices for patients with refractive errors is wider than it has been at any point in the profession’s history.

For independent practice, the myopia management opportunity is structural. It requires continuity of care, a consistent team clinical message, and a long-term patient relationship. These are precisely the conditions that a well-run independent practice provides as standard — and that a high-volume corporate model finds genuinely difficult to replicate.

Contact lenses are doing things that were not possible five years ago.

The development pipeline for contact lens technology has moved into territory with direct clinical implications. Augmented reality is now being incorporated into contact lenses that track blinking and enable wireless interaction with machines. Smart contacts are in development to diagnose ocular conditions. Integrated biosensors in contact lenses can measure intraocular pressure in real time, continuously monitoring pressure changes. These same lenses are being developed to release anti-glaucoma medication directly.

Separately, telescopic contact lenses are in development with the potential to transform how age-related macular degeneration is managed. None of these is yet on the prescribing list. But the direction of travel is clear — contact lenses are evolving from refractive correction devices into multi-functional clinical tools.

Practices that are building specialist contact lens-fitting expertise and clinical relationships with complex-needs patients now are developing the capabilities that will be directly relevant to this pipeline as it matures.

Eyewear is acquiring capabilities beyond vision correction.

The same convergence of technology is visible in frame and lens development. EssilorLuxottica’s Nuance Audio glasses combine vision correction with integrated hearing aids for patients with mild-to-moderate hearing loss, alongside an app that adjusts audio settings based on the surrounding environment—a single frame, dispensed by an optician, addresses two separate sensory needs.

In augmented reality eyewear, Meta’s Orion glasses incorporate large holographic displays for both 2D and 3D digital elements. Xreal’s AR glasses, powered by the X1 chip, allow direct viewing of digital content from the frame itself.

What each of these products shares is a dispensing conversation that is longer, more detailed and more clinically complex than a standard frame selection. They require a practitioner who understands both the optics and the technology — and a patient relationship that supports such a consultation. Independent practice is well placed to have that conversation.

What independent practices should take from this?

Practising optometrist Paul Levine, based in Southborough, Massachusetts, described the current moment as a very exciting time to be in eye care, with innovations not previously available now becoming practical clinical tools. For practitioners committed to clinical excellence and long-term patient relationships, the technology is additive. It makes what independent practice already does well more precise, better documented and more impactful.

The practices that will benefit most are those that approach these developments as clinical tools rather than marketing propositions. AI diagnostics that support a richer patient conversation. Myopia management services are built around the full practice team. Contact lens fitting expertise was developed ahead of the pipeline rather than in response to it. Eyewear dispensing capability that can handle technically complex products as they arrive.

None of that requires an independent practice to become a technology company. It requires independent practice to stay clinically current and to deliberately use what is available.

This is exactly the kind of conversation our Grow Independent service is designed for. Book a Free 20-Minute Practice Growth Call